Abstract: A charger control apparatus includes a total current acquisition unit and a setting unit to control a plurality of chargers connected in parallel with each other and supplied with a current from a common wiring line. An upper limit value of a current flowing through the wiring line is described as a first upper limit value. The total current acquisition unit acquires a total value of a current flowing through the plurality of chargers. The setting unit sets, for each of the plurality of chargers, a second upper limit value being an upper limit value of a current flowing through the charger by using the first upper limit value. When a difference between the total value and the first upper limit value satisfies a reference, the setting unit updates the second upper limit value for each of the plurality of chargers by distributing the difference according to a first rule.

Abstract: An image forming method includes operating, receiving, and setting. The operating includes operating in an operation mode of a plurality of operation modes. The operation modes includes a first electric power mode configured to perform an image formation process and a second electric power mode configured to consume a power less than a power of the first electric power mode and not to perform the image formation process. The receiving includes receiving a print job. The setting includes switching the operation mode to the second electric power mode after a lapse of a preset first standby period after a completion of the print job. When the print job including a sleep transition command is received in the second time slot, the switching includes switching the operation mode to the second electric power mode before the lapse of the first standby period.

Abstract: A method of generating a status report from an image forming device comprises: recording an error notification in real time from the image forming device; analyzing the error notification received, wherein analyzing the error notification comprises: detecting a sequential pattern in the recorded error notification; and analyzing the sequential pattern detected; sending a request to the image forming device for a first status report if the sequential pattern detected in the error notification matches one of pre-stored sequential patterns corresponding to an error for which the first status report is requested; receiving the first status report using bidirectional communication protocols; analyzing data in the first status report; diagnosing the image forming device based on the data analyzed; and generating an action request.

Abstract: An image forming method includes operating, receiving, and setting. The operating includes operating in an operation mode of a plurality of operation modes. The operation modes includes a first electric power mode configured to perform an image formation process and a second electric power mode configured to consume a power less than a power of the first electric power mode and not to perform the image formation process. The receiving includes receiving a print job. The setting includes switching the operation mode to the second electric power mode after a lapse of a preset first standby period after a completion of the print job. When the print job including a sleep transition command is received in the second time slot, the switching includes switching the operation mode to the second electric power mode before the lapse of the first standby period.

Abstract: Provided is an image forming system that reduce a paper jam. The system includes an image forming apparatus and a server to manage the image forming apparatus. A paper jam information receiving part in the server receives paper jam information transmitted from the image forming apparatus. A paper jam information analyzing part analyzes paper jam information. A paper jam information analyzing part generates feed-setting changing information when the feed number of the recording paper in the paper feed source where the paper jam occurred corresponds to a threshold and another paper feed source with same settings of a recording paper is present. Feed-setting changing information is information instructed to change into the respective paper feed source. A feed-setting changing information transmitting part transmits feed-setting changing information to the image forming apparatus.

Abstract: A method of generating a status report from an image forming device comprises: recording an error notification in real time from the image forming device; analyzing the error notification received, wherein analyzing the error notification comprises: detecting a sequential pattern in the recorded error notification; and analyzing the sequential pattern detected; sending a request to the image forming device for a first status report if the sequential pattern detected in the error notification matches one of pre-stored sequential patterns corresponding to an error for which the first status report is requested; receiving the first status report using bidirectional communication protocols; analyzing data in the first status report; diagnosing the image forming device based on the data analyzed; and generating an action request.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: Provided is a license management system comprising: a license check device that independently operates on a platform; and an information processing device that is connected to the license check device, in which the license check device includes: a license check unit that checks for presence or absence of a license of the information processing device; a first start unit that starts the license check unit in response to a call instructed by the platform; and a calling unit that calls, when the license check unit determines that the license is present, the information processing device, and in which the information processing device includes: an information processing unit that performs a specific information processing; and a second start unit that starts the information processing unit only in response to the call from the license check device.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: A method for preparing a xanthohumol-rich hop composition. The method includes providing a solution that contains xanthohumol-containing hop substances and effecting precipitation of non-xanthohumol hop substances by adjusting both the salt concentration and pH value of the solution. The xanthohumol-rich hop composition prepared by this method can be used for treating various diseases, e.g., skin disorders, and bacterial infection.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: The inventors discovered that the adhesion molecule CAR, known to be localized in intracellular adhesion sites, functioned as an adhesion molecule for activated lymphocytes. Further, the inventors identified CARL, a novel CAR ligand expressed in lymphocytes, and clarified that the ligand was expressed selectively in Th1 cells. In addition, they found that anti-CAR antibodies could inhibit the adhesion of activated lymphocytes to CAR molecules. Thus, the present invention provides methods for detecting Th1 cells using CAR or anti-CARL antibodies, and methods of screening for inhibitors suppressing the adhesion of Th1 cells using the binding between CAR and CARL as an index. Furthermore, the present invention relates to methods of screening for inhibitors of the binding between CAR and CARL, antibodies that inhibit the binding between CAR and CARL, and therapeutic compositions comprising these antibodies.

Abstract: The present invention features therapeutic and prophylactic compositions comprising xanthohumol and/or xanthohumol/cyclodextrin complexes and methods of using such compositions for treating a skin condition, disease, or disorder.

Abstract: When a processing delay detection unit (27) detects that an end timing (F) of measurement of the reception quality of a common pilot signal transmitted from a wireless base station has delayed from a creation start time limit for reception quality information, approximate reception quality information (k) is created on the basis of reception quality measured before the creation start time limit. The approximate reception quality information is transmitted to a wireless base station. The delay of the transmission timing of the reception quality information can be prevented, and the wireless base station can quickly set the transmission rate of transmission data to a cellular phone.

Abstract: A method for preparing a xanthohumol-rich hop composition. The method includes providing a solution that contains xanthohumol-containing hop substances and effecting precipitation of non-xanthohumol hop substances by adjusting both the salt concentration and pH value of the solution. The xanthohumol-rich hop composition prepared by this method can be used for treating various diseases, e.g., skin disorders, and bacterial infection.

Abstract: Provided is a license management system comprising: a license check device that independently operates on a platform; and an information processing device that is connected to the license check device, in which the license check device includes: a license check unit that checks for presence or absence of a license of the information processing device; a first start unit that starts the license check unit in response to a call instructed by the platform; and a calling unit that calls, when the license check unit determines that the license is present, the information processing device, and in which the information processing device includes: an information processing unit that performs a specific information processing; and a second start unit that starts the information processing unit only in response to the call from the license check device.